(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/j8GjXSK5mig/fda-allows-alnylam-to-restart-hemophilia-treatment-trials-idINKBN1E91EP
Posted by Equitymaster On Thursday, Indian share markets closed volatile session on stronger note as the benchmark indices rallied ahead of Gujarat... ...http://www.equitymaster.com/tm/tm.asp?date=12/15/2017&title=ECB-BoE-Meetings-WPI-Inflation-Gujarat-Exit-Poll--Top-Cues-to-Move-Markets-Today
(Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/jeXpE3wKh7I/pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-idINKBN1E902X
Posted by Equitymaster After trading on a flat note in the noon session, Indian share markets witnessed buying momentum in the afternoon session... ...http://www.equitymaster.com/tm/tm.asp?date=12/14/2017&title=Sensex-Finishes-on-a-Firm-Note-Pharma-Stocks-Rise
Drug major Lupin today said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the... ...http://www.business-standard.com/article/pti-stories/lupin-gets-usfda-nod-for-generic-contraceptive-tablets-117121400617_1.html
An additional reason precisely why...